Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Nanjing Shunxiang Pharmaceutical Technology Co., Ltd. is a high-tech enterprise based in Nanjing, China, specializing in the research, development, and large-scale production of pharmaceutical chemical intermediates and active pharmaceutical ingredients (APIs). Established in 2016, with roots in a pioneering factory founded in 1999, the company is a leading global supplier of amino protectants, azo series, and pyridine series chemicals, including Di-tert-butyl dicarbonate (Di-Boc) and Diisopropyl azodicarboxylate (DIAD). It operates multiple production bases, such as the Lanzhou Tengxing biological plant, and serves major international pharmaceutical companies including Pfizer, Novartis, and Abbott. The company also maintains chemical information platforms like ChemMade.com to support the global chemical industry chain.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Nanjing Shunxiang Pharm.